Product Name | MAP3K8 (Phospho-Ser400) Antibody |
Synonyms | COT proto-oncogene serine/threonine-protein kinase; C-COT; Cancer Osaka thyroid oncogene; Tumor progression locus 2; TPL-2 |
Immunogen | The antiserum was produced against synthesized peptide derived from human MAP3K8 around the phosphorylation site of Ser400. |
Immunogen Region | C-terminal |
Clonality | Polyclonal |
Modification sites | H:S400 M:S400 R:S400 |
Application dilutions | IHC: 1:50~1:100 ELISA: 1:1000 |
Specificity | MAP3K8 (Phospho-Ser400) Antibody detects endogenous levels of MAP3K8 only when phosphorylated at serine400. |
Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation. |
Physical Form | Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
Concentration | 1 mg/ml |
Storage/Stability | Store at -20℃/1 year |